- Legal victory against counterfeit sellers protects InMode's intellectual property and brand value.
- Court-ordered asset freeze and removal of counterfeit product listings strengthen InMode's market position.
- Verified Provider Program enhances customer safety and brand trust in a competitive market.
InMode Ltd. (INMD, Financial) has achieved a significant legal triumph with the U.S. District Court for the Central District of California granting a default judgment against sellers on the DHGate platform dealing in counterfeit Morpheus8 radio frequency microneedling devices and needle cartridges. This judgment includes a permanent injunction against further infringement of InMode's trademarks and an award of damages. The court's decision mandates the freezing of the defendants' assets and the removal of their product listings.
This legal win addresses issues of trademark infringement, false designation of origin, and California unfair competition, bolstering InMode's efforts to protect its brand integrity in the medical aesthetics industry. Counterfeit products pose significant risks, not only to InMode’s revenue but also to patient safety due to the unverified nature of these counterfeit devices.
InMode has instituted a Verified Provider Program for its Morpheus8 devices, equipping certified clinics with a means to demonstrate their authenticity. Patients can verify authorized providers through InMode's "Find a Provider" tool available at www.inmodemd.com. This initiative is a strategic move to ensure patient safety and uphold the quality associated with InMode's products.
CEO Moshe Mizrahy highlights InMode's zero-tolerance policy towards fraudulent business practices and reaffirms their dedication to safeguarding public safety. The Verified Provider Program not only protects consumers but also strengthens InMode's competitive position by enhancing trust in their brand.
For more information about InMode's array of medical technologies, visit their website at www.inmodemd.com.
